Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

MHS1

Sigma-Aldrich

Mayer′s Hematoxylin Solution

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Número MDL:
Código UNSPSC:
41116124
ID de substância PubChem:
NACRES:
NA.47

Formulário

solution

prazo de validade

Expiry date on the label.

IVD

for in vitro diagnostic use

concentração

1 g/L

pH

2.4 (25 °C)

aplicação(ões)

hematology
histology

temperatura de armazenamento

room temp

cadeia de caracteres SMILES

Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O

InChI

1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1

chave InChI

WZUVPPKBWHMQCE-XJKSGUPXSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

Used as a counterstain for procedures such as immunohistochemistry or laser microdissection.

Aplicação

General purpose nuclear stain, progressive type. Used with hematoxylin and eosin staining.

Outras notas

1 g/L certified hematoxylin

Código de classe de armazenamento

12 - Non Combustible Liquids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Michael Taylor Hensley et al.
Journal of cellular and molecular medicine, 21(8), 1503-1512 (2017-03-16)
Cardiosphere-derived cells (CDCs) have been shown to reduce scar size and increase viable myocardium in human patients with mild/moderate myocardial infarction. Studies in rodent models suggest that CDC therapy may confer therapeutic benefits in patients with non-ischaemic dilated cardiomyopathy (DCM).
Shih-Jie Jhuo et al.
International journal of molecular sciences, 22(11) (2021-07-03)
Empagliflozin (EMPA) is a sodium-glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases. However, the possible benefits and mechanisms of its antiarrhythmic effects in cardiac
Gretchen M Alicea et al.
Cancer discovery, 10(9), 1282-1295 (2020-06-06)
Older patients with melanoma (>50 years old) have poorer prognoses and response rates to targeted therapy compared with young patients (<50 years old), which can be driven, in part, by the aged microenvironment. Here, we show that aged dermal fibroblasts
Darby A Houck et al.
Orthopaedic journal of sports medicine, 7(12), 2325967119888173-2325967119888173 (2020-01-07)
Arthroscopic capsular release (ACR) for the treatment of adhesive capsulitis of the shoulder can be performed in either the beach-chair (BC) or lateral decubitus (LD) position. To determine the clinical outcomes and recurrence rates after ACR in the BC versus
Amanpreet Kaur et al.
Cancer discovery, 9(1), 64-81 (2018-10-04)
Physical changes in skin are among the most visible signs of aging. We found that young dermal fibroblasts secrete high levels of extracellular matrix (ECM) constituents, including proteoglycans, glycoproteins, and cartilage-linking proteins. The most abundantly secreted was HAPLN1, a hyaluronic

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica